Nektar Therapeutics Presents Pre-Clinical Data Combining NKTR 214 With Checkpoint Blockade
April 18, 2016 at 10:09 AM EDT
Nektar Therapeutics (NASDAQ: NKTR) disclosed fresh preclinical data for its investigational immune-stimulatory cytokine therapy, ...